Assessment of best corrected visual acuity in type 2 diabetic patients with meibomian gland dysfunction | ||
| Minia Journal of Medical Research | ||
| Articles in Press, Accepted Manuscript, Available Online from 08 January 2024 | ||
| Document Type: Original Article | ||
| DOI: 10.21608/mjmr.2024.256530.1569 | ||
| Authors | ||
| Walaa Mahmoud Mostafa Kamal* 1; Mohamed Salah El-Din Mahmoud2; Raafat MA Abdallah3; Ahmed Eid4 | ||
| 1.Ophthalmology department, faculty of medicine , Minia university. | ||
| 2Ophthalmology department ,MInia university | ||
| 3professor of ophthalmology faculty of medicine, Minia university | ||
| 4MD, department ophthalmology, faculty of medicine, Minia University | ||
| Abstract | ||
| Introduction: Meibomian gland dysfunction (MGD)is considered an inflammatory state and a trigger for evaporative dry eye disease (DED) (1). Aim of the study: Assessment of visual acuity in patients with MGD including type 2 diabetic patients. Patients and methods: This was a case control study; the study was conducted on 90 eyes of 90 patients with meibomian gland dysfunction were randomly classified into 3 groups, and assessment of visual acuity was done in each group. The study was done in Ophthalmology department, Minia University Hospital, Egypt between December 2022 to May 2023. Results: There was a significant difference between the 3 groups in best corrected visual acuity (BCVA) in patients with meibomian gland dysfunction, more pronounced in patients with Diabetes mellitus (DM). Conclusion: In patients with MGD, BCVA was affected especially in type 2 diabetic patients. Presence of hyperglycemia leads to MGD and causes evaporative dry eye disease, which consequently leads to poor vision. | ||
| Keywords | ||
| Meibomian gland dysfunction; diabetes mellitus; best corrected visual acuity | ||
|
Statistics Article View: 137 |
||
